美国血液技术 HAE 深 沪
等待开盘 10-22 09:30:00 美东时间
50.95
+0.240
+0.47%
华盛通- 最 高51.21
- 今 开50.93
- 成交量 24.08万股
- 最 低 50.455
- 昨 收 50.71
- 总市值 24.48亿
- 52周最高 94.985
- 市盈率 静 15.41
- 换手率 0.50%
- 52周最低 47.315
- 委 比 0.00%
- 总股本 4804.12万
- 历史最高 142.11
- 量 比 0.35
- 振 幅 1.49%
- 历史最低 25.98
- 每 手 1
- 风险率 10.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioCryst to buy Astria Therapeutics for $13 per share
BioCryst Pharmaceuticals (NASDAQ:BCRX) has agreed to acquire biopharmaceutical firm Astria Therapeutics (NASDAQ:ATXS) for a mix of cash and stock representing an implied value of $13.00 per Astria sha...
10-14 19:20
How Do Investors Really Feel About Haemonetics Corp?
Haemonetics Corp's (NYSE:HAE) short interest as a percent of float has fallen 7...
10-13 21:01
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
Citigroup Maintains Buy on Haemonetics, Lowers Price Target to $64
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Buy and lowers the price target from $78 to $64.
10-08 01:06
Astria Therapeutics Begins Opening Clinical Trial Sites In EU And May Begin Screening Participants For Phase 3 ALPHA-ORBIT Trial Of Navenibart For HAE Treatment
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it has begun opening clinical trial sites in
10-02 20:06
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
9 Analysts Have This To Say About Haemonetics
Across the recent three months, 9 analysts have shared their insights on Haemon...
09-24 02:01
Barrington Research Maintains Outperform on Haemonetics, Maintains $86 Price Target
Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $86 price target.
09-23 23:10
Intellia Therapeutics Shares Are Ripping Higher: Here's Why
Intellia Therapeutics Inc (NASDAQ:NTLA) shares are soaring on Thursday after the company completed enrollment in its crucial Phase 3 HAELO trial and laid out its key development milestones.
09-19 02:33
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points...
09-18 22:19
